Alexander Black, MD
Medical Oncologist
Asbestosis Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Dr. Alexander Black is a medical oncologist based in Valencia, California. He has an extensive medical experience of 34 years. He graduated in 1983 from the Columbia University College of Physicians and Surgeons. He continued afterward with an internship stage at the Columbia-Presbyterian Medical Center and a residency at the same institution. After this stage, he completed his fellowship at UCLA. Dr. Alexander Black is a board-certified specialist in three clinical areas: internal medicine, hematology, and oncology. He contributed to two published studies and articles that focused on topics like Dichloroacetate in hypoxic tumors and myelopathy after radiation therapy. He is also a co-author of several articles covering areas like chemotherapy, hematological and immunological analysis of 21 HTLV II, HTLV II Rex protein binds specifically to RNA sequences. At the moment, Dr. Black is affiliated with Henry Mayo Newhall Hospital in Valencia, Huntington Memorial Hospital in Pasadena, Ronald Reagan UCLA Medical Center in Los Angeles, UCLA Medical Center-Santa Monica.
Columbia University College of Physicians & Surgeons
Medical School
Columbia-Presbyterian Medical Center, Columbia University
Internship
Columbia-Presbyterian Medical Center, Columbia University
Residency
UCLA
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
Henry Mayo Newhall Memorial Hospital
Languages: English/Spanish
(661) 200-2000
23845 McBean Pkwy
Read MoreRonald Reagan UCLA Medical Center
Languages: English/Spanish
(310) 825-9111
757 Westwood Plaza
Read MoreUCLA Medical Center, Santa Monica
Languages: English/Spanish
(424) 259-6000
1250 16th St
Santa Monica, California 90404
Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer.
Garon, E. B.,Christofk, H. R.,Hosmer, W.,Britten, C. D.,Bahng, A.,Crabtree, M. J.,Hong, C. S.,Kamranpour, N.,Pitts, S.,Kabbinavar, F.,Patel, C.,von Euw, E.,Black, A.,M...; J. Cancer Res. Clin. Oncol.. 2014 Jan 21.
See more >>Myelopathy after radiation therapy and chemotherapy with capecitabine and gemcitabine.
Barstis, J.L., Black, A.C.; Cancer Invest. 2005.
See more >>